Fedha

Hisa unazofuatilia
Kwa nini NBIX imepungua kwa 4.41%?
Fahamu zaidi
NBIX:NASDAQ
Neurocrine Biosciences, Inc
US$ 135.13
-4.41%
(-6.24) Siku 1
US$ 135.50
+0.27% (+0.37)
Baada ya saa
Imefungwa: 13 Okt, 16:00:00 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya NBIX...
Fungua
US$ 139.60
Juu
US$ 139.92
Chini
US$ 134.89
Mtaji wa soko
13.74B
Wastani wa kiasi cha mauzo
1.30M
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
19.81
Juu kwa wiki 52
US$ 186.12
Chini kwa wiki 52
US$ 122.14
EPS
US$ 6.82
Beta
0.40
Hisa za wawekezaji
101.65M
Idadi ya wafanyakazi
elfu 2
Fungua
US$ 139.60
Juu
US$ 139.92
Chini
US$ 134.89
Mtaji wa soko
13.74B
Wastani wa kiasi cha mauzo
1.30M
Kiasi cha mauzo ya hisa
0.00
Uwiano wa bei ya hisa na mapato kwa kila hisa
19.81
Juu kwa wiki 52
US$ 186.12
Chini kwa wiki 52
US$ 122.14
EPS
US$ 6.82
Beta
0.40
Hisa za wawekezaji
101.65M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine was approved in the US to treat adults with tardive dyskinesia. The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids. Wikipedia
Kuhusu Neurocrine Biosciences, Inc
Afisa Mkuu Mtendaji (CEO)Kevin C. Gorman
Wafanyakazielfu 2.5
Lilianzishwa1992
Makao makuuSan Diego, California, Marekani
Sekta-
Tovutineurocrine.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 26 waliotoa ukadiriaji wa hisa kwa NBIX katika miezi 3 iliyopita
Imenunuliwa sana
Nunua
23
Shikilia
3
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 26 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya NBIX katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 135.13
US$ 253.00 (+87.23%)
Wastani
US$ 207.28 (+53.39%)
Chini kabisa
US$ 150.00 (+11.00%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Mohit Bansal
Wells Fargo
Buy
Maintained
US$ 200.00
+48%
10/13/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$ 187.00
+38.4%
10/13/2026
Evan Seigerman
BMO Capital
Hold
Maintained
US$ 150.00
+11%
10/12/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
US$ 214.00
+58.4%
10/09/2026
David Amsellem
Piper Sandler
Buy
Reiterated
US$ 210.00
+55.4%
10/09/2026
Delma Caiati
Guggenheim
Buy
Initiated
US$ 207.00
+53.2%
10/05/2026
Yatin Suneja
Guggenheim
Buy
Initiated
US$ 207.00
+53.2%
10/05/2026
Akash Tewari
Jefferies
Buy
Maintained
US$ 220.00
+62.8%
09/29/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ 220.00
+62.8%
09/29/2026
Ashwani Verma
UBS
Buy
Reiterated
US$ 214.00
+58.4%
09/28/2026
Jeffrey Walch
Bernstein
Buy
Maintained
US$ 218.00
+61.3%
09/25/2026
Unknown Analyst
CCB Intl.
Buy
Initiated
US$ 188.00
+39.1%
09/18/2026
Sean Laaman
Morgan Stanley
Hold
Reiterated
US$ 183.00
+35.4%
09/11/2026
Yigal Nochomovitz
Citi
Buy
Maintained
US$ 253.00
+87.2%
09/04/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
US$ 215.00
+59.1%
08/17/2026
David Hoang
Deutsche Bank
Hold
Reiterated
US$ 165.00
+22.1%
08/13/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
US$ 217.00
+60.6%
08/06/2026
Laura Chico
Wedbush
Buy
Maintained
US$ 194.00
+43.6%
08/03/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
US$ 210.00
+55.4%
08/03/2026
Danielle Brill
Truist Financial
Buy
Maintained
US$ 213.00
+57.6%
08/03/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
US$ 215.00
+59.1%
07/31/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
07/31/2026
Jay Olson
Oppenheimer
Buy
Maintained
US$ 230.00
+70.2%
07/31/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
US$ 215.00
+59.1%
07/30/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
US$ 225.00
+66.5%
07/31/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
US$ 215.00
+59.1%
07/31/2026
Ami Fadia
Needham
Buy
Reiterated
US$ 204.00
+51%
07/31/2026
Phil Nadeau
TD Cowen
Buy
Reiterated
US$ 220.00
+62.8%
07/31/2026
Corinne Johnson
Goldman Sachs
Buy
Initiated
US$ 213.00
+57.6%
06/02/2026
Unknown Analyst
Bernstein
Buy
Initiated
US$ 221.00
+63.5%
05/21/2026
Nevin Varghese
RBC Capital
Buy
Reiterated
US$ 180.00
+33.2%
05/11/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
US$ 175.00
+29.5%
05/06/2026
Rudy Li
Wolfe Research
Buy
Reiterated
US$ 160.00
+18.4%
04/06/2026
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
US$ 199.00
+47.3%
04/06/2026
Ripoti ya mwisho
30 Jul 2026
Kipindi cha Kifedha
Robo2 2026
US$ 2.85 / US$ 1.96
+45.44%umepitiliza
Mapato dhidi ya makadirio (USD)
959.00M / 890.33M
+7.71%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
794.90M
805.50M
814.50M
959.00M
Gharama ya bidhaa zilizouzwa
264.00M
275.80M
310.00M
346.70M
Gharama ya mapato
264.00M
275.80M
310.00M
346.70M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
291.60M
302.50M
318.50M
383.10M
Gharama ya uendeshaji
291.60M
302.50M
318.50M
399.50M
Jumla ya gharama za uendeshaji
555.60M
578.30M
628.50M
746.20M
Mapato ya uendeshaji
239.30M
227.20M
186.00M
212.80M
Mapato mengine yasiyo ya uendeshaji
-
-
-
-
EBT ikijumuisha vipengee visivyo vya kawaida
291.80M
239.40M
246.80M
162.20M
EBT bila kujumuisha vipengee visivyo vya kawaida
261.50M
253.00M
214.10M
222.30M
Gharama ya kodi ya mapato
82.30M
85.70M
48.90M
17.80M
Kiwango cha kodi kinachotumika
28.20%
35.80%
19.81%
10.97%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
209.50M
153.70M
197.90M
144.40M
Kiwango cha faida halisi
26.36%
19.08%
24.30%
15.06%
Mapato kwa kila hisa
2.17
1.88
1.94
2.85
Mapato ya riba na uwekezaji
22.20M
25.80M
28.10M
12.40M
Gharama ya riba
-
-
-
-2.90M
Jumla ya gharama halisi za riba
22.20M
25.80M
28.10M
9.50M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
247.00M
234.70M
193.30M
237.60M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-28.60M
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google